首页/数据集/XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants

XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants

NCATS Open Data2024-02-12 更新2026-08-08 收录

新冠病毒疫苗免疫原性

中和抗体评估

数据链接：

https://doi.org/10.1101/2024.02.03.578771 数据链接链接失效反馈

官方服务：

资源简介：

XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants

应用场景：

创建时间：

2024-02-05

病毒载体疫苗

中和抗体评估

Additional file 1: Table S1. Vaccines are adopted in several systems and have different immune responses.

Figshare2023-02-09 更新20

Dataset for 'Identification of immunodominant T cell epitopes in SARS-CoV-2 spike protein in Syrian hamsters'

T细胞表位

新冠病毒疫苗免疫原性

This dataset contains all raw data underlying the main and supplementary figures of the manuscript “Identification of Immunodominant T Cell Epitopes in the SARS-CoV-2 Spike Protein in Syrian Hamsters”

NIAID Data Ecosystem10

A three component mix of thioredoxin-L2 antigens elicits broadly neutralizing responses against oncogenic human papillomaviruses.

HPV疫苗研发

中和抗体评估

The L1 pseudovirion-based neutralization assay (L1-PBNA) was used to determine immunogenicity and cross-reactivity of peptide 20-38 constructs.

ImmuneData10

Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques

HIV疫苗免疫原设计

中和抗体评估

The identification of HIV envelope structures that generate broadly cross-reactive neutralizing antibodies is a major goal for HIV-vaccine development. In this study, we evaluated one such structure,

PubMed Central2002-08-21 更新20

Studies of the Neutralizing Activity and Avidity of Anti-Human Immunodeficiency Virus Type 1 Env Antibody Elicited by DNA Priming and Protein Boosting

HIV-1疫苗

中和抗体评估

DNA vaccination is an effective means of eliciting strong antibody responses to a number of viral antigens. However, DNA immunization alone has not generated persistent, high-titer antibody and neutra

PubMed Central10

XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants

资源简介：

相关数据集